This article is more than 5 years old. Information may no longer be current.
Rutgers Cancer Institute of New Jersey names new director
Click Here to Manage Email Alerts
Steven K. Libutti , MD, FACS, has been appointed director of Rutgers Cancer Institute of New Jersey.
He will take over for Bruce G. Haffty, MD, who has served as interim director and will continue in his role as chair of radiation oncology.
Libutti also will serve as vice chancellor for cancer programs for Rutgers Biomedical and Health Sciences at Rutgers University, as well as senior vice president of oncology services for RWJBarnabas Health.
“Through his vast leadership and oncology expertise, Dr. Libutti will implement a unique vision to position Rutgers Cancer Institute of New Jersey as one of the top National Cancer Institute-designated Comprehensive Cancer Centers in the country as well as expand its impact throughout the RWJBarnabas Health System and the state,” Brian L. Strom, MD, MPH, Rutgers Biomedical and Health Sciences chancellor and executive vice president for health affairs, said in a press release. “We look forward to this new chapter in the history of Rutgers Cancer Institute of New Jersey, and together we will make an exceptional program even better.”
Libutti — a surgical oncologist recognized for his expertise in endocrine surgery and the management of neuroendocrine tumors — previously served as director of Montefiore Einstein Center for Cancer Care in New York. He also served as professor and vice chairman of the department of surgery and professor in the department of genetics at Albert Einstein College of Medicine and Montefiore Health System.
Libutti — whose clinical practice focuses on gastrointestinal malignancies, including cancers of the liver and pancreas — is immediate past president of the American Association of Endocrine Surgeons.
“I am honored to have been chosen to lead Rutgers Cancer Institute of New Jersey during this pivotal time in its history,” Libutti said in the release. “As the state’s cancer center, it is part of our mission to advance the understanding of the inner workings of cancer as it is a disease that impacts so many. Cooperative efforts between internationally recognized scientists at Rutgers Cancer Institute of New Jersey, industry, academia and other collaborators will help us further accomplish this goal.”